Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol

BMC Cancer

Kathleen Clouston¹  Alan Katz⁵  Patricia J Martens⁷  Jeff Sisler⁴  Donna Turner³  Michelle Lobchuk⁶  Susan McClement² 

[1] Department of Family Medicine Research, Faculty of Medicine, University of Manitoba, P228-770, Bannatyne Ave, Winnipeg, MB R3E 0W3, Canada

[2] Professor, Faculty of Nursing, University of Manitoba; Research Associate, Manitoba Palliative Care, Research Unit, CancerCare Manitoba, Manitoba, Canada

[3] Population Oncology, CancerCare Manitoba, Department of Community Health Sciences, Faculty of Medicine, University of Manitoba, Manitoba, Canada

[4] Director, Primary Care Oncology Program, CancerCare Manitoba; Associate Professor, Departments of Family Medicine and Internal Medicine, University of Manitoba; Chair, Canadian Association of General Practitioners in Oncology, Manitoba, Canada

[5] Departments of Family Medicine (Research Director) and Community Health Sciences, Faculty of Medicine, University of Manitoba, P228-770 Bannatyne Ave, Winnipeg, MB R3E 0W3, Canada

[6] Associate Professor, Faculty of Nursing, University of Manitoba, Manitoba, Canada

[7] Professor, Department of Community Health Sciences, Manitoba Centre for Health Policy (Director), Faculty of Medicine, University of Manitoba, Manitoba, Canada

关键词: Knowledge exchange;    Integrated knowledge translation;    Cluster randomized controlled trial;    Pragmatic;    Patient decision aid;    Family physicians;    Community-based clinical practice;    Community-based Primary healthcare research;    Fecal occult blood test;    Colorectal cancer screening;   

Others  :  1080425
DOI  :  10.1186/1471-2407-12-182

 received in 2012-03-22, accepted in 2012-04-30,  发布年份 2012

【 摘 要 】

Background

Fecal occult blood test screening in Canada is sub-optimal. Family physicians play a central role in screening and are limited by the time constraints of clinical practice. Patients face multiple barriers that further reduce completion rates. Tools that support family physicians in providing their patients with colorectal cancer information and that support uptake may prove useful. The primary objective of the study is to evaluate the efficacy of a patient decision aid (nurse-managed telephone support line and/or colorectal cancer screening website) distributed by community-based family physicians, in improving colorectal cancer screening rates. Secondary objectives include evaluation of (dis)incentives to patient FOBT uptake and internet use among 50 to 74 year old males and females for health-related questions. Challenges faced by family physicians in engaging in collaborative partnerships with primary healthcare researchers will be documented.

Methods/design

A pragmatic, two-arm, randomized cluster controlled trial conducted in 22 community-based family practice clinics (36 clusters) with 76 fee-for-service family physicians in Winnipeg, Manitoba, Canada. Each physician will enroll 30 patients attending their periodic health examination and at average risk for colorectal cancer. All physicians will follow their standard clinical practice for screening. Intervention group physicians will provide a fridge magnet to each patient that contains information facilitating access to the study-specific colorectal cancer screening decision aids (telephone help-line and website). The primary endpoint is patient fecal occult blood test completion rate after four months (intention to treat model). Multi-level analysis will include clinic, physician and patient level variables. Patient Personal Health Identification Numbers will be collected from those providing consent to facilitate analysis of repeat screening behavior. Secondary outcome data will be obtained through the Clinic Characterization Form, Patient Tracking Form, In-Clinic Patient Survey, Post-Study Follow-Up Patient Survey, and Family Physician Survey. Study protocol approved by The University of Manitoba Health Research Ethics Board.

Discussion

The study intervention has the potential to increase patient fecal occult blood test uptake, decrease colorectal cancer mortality and morbidity, and improve the health of Manitobans. If utilization of the website and/or telephone support line result in clinically significant increases in colorectal cancer screening uptake, changes in screening at the policy- and system-level may be warranted.

Trial registration

Clinical trials.gov identifier NCT01026753

【 授权许可】

   
2012 Clouston et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Canadian Cancer Society: Canadian Cancer Society: Canadian Cancer Statistics, 2011. Toronto; 2011. [http://www.cancer.ca webcite]
• [2]Canadian Partnership Against Cancer: Colorectal Screening in Canada: Current Facts and Resources. Resource Library; October, 2010. [http://www.cancerview.ca. webcite]
• [3]PRA Inc: Colorectal cancer screening: Results of a survey of Manitobans 50–74. Manitoba; 2008. [http://www.cancercare.mb.ca/resource/File/CRC/Background_ColonCheck_Manitoba_Sept09.pdf webcite]
• [4]Statistics Canada: Study: Mammography use and colorectal cancer testing. 2009. [http://www.statcan.gc.ca/daily-quotidien/090630/dq090630c-eng.htm webcite]
• [5]Hewitson P, Glasziou P, Watson E, Towler B, Irwig L: Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): An update. Am J Gastroenterol 2008, 103(6):1541-1549.
• [6]Flanagan WM, Le Petit C, Berthelot JM, White KJ, Coombs BA, Jones-McLean E: Potential impact of population-based colorectal cancer screening in Canada. Chronic Dis Can 2003, 24(4):81-88.
• [7]Kliewer EV, Wajda A, Blanchard JF: Manitoba Cancer Project: The increasing cancer burden. 2001, 1995-2025.
• [8]Canadian Partnership Against Cancer. 2010. [Cancer Control Spotlight: Colorectal Cancer screening] www.cancerview.ca/idc/groups/public/documents/webcontent/rl_cancer_1crcscreen.pdf webcite
• [9]CancerCare Manitoba: Colorectal Cancer Five Year Survival Report. Manitoba; 2009.
• [10]Hewitson P, Glasziou P, Irwig L, Towler B, Watson E: Screening for colorectal cancer using the fecal occult blood test, Hemoccult. Cochrane Database of Systemic Review 2007, Jan 24, (1):CD001216.
• [11]Leddin D, Hunt R, Champion M, Cockeram A, Flook N, Gould M, Kim YI, Love J, Morgan D, Nutsheh S, Sadowski D: Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol 2004, 18:93-99.
• [12]Canadian Task Force on Preventive Health Care: Colorectal cancer screening: Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001, 165:206-208.
• [13]Public Health Agency of Canada: Technical Report for the National Committee on Colorectal Cancer Screening. May, 2002. [http://www.publichealth.gc.ca webcite]
• [14]Statistics Canada: Colorectal cancer testing in Canada-2008, Research Article. September, 2009. [Statistics Canada, Catalogue no. 82-003-XPE; Health Reports]
• [15]Yarnall KS, Pollak KI, Østbye T, Krause KM, Michener LJ: Priamry Care: Is there enough time for prevention? Am J Public Health 2003, 93(4):635-641.
• [16]Fortin M, Lapointe L, Hudon C, Vanasse A: Multimorbidity is common to family practice: is it commonly researched? Can Fam Physician 2005, 51:244-245.
• [17]Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L: Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 2005, 3:223-228.
• [18]Carter RE, Rose DA, Palesch YY, Mintzer JE: Alzheimer’s disease in the family practice setting: Assessment of a screening tool. Prim Care Companion J Clinical Psychiatry 2004, 6(6):234-238.
• [19]Health Council of Canada: Decisions, Decisions: Family doctors as gatekeepers to prescription drugs and diagnostic imaging in Canada. September, 2010. [http://healthcouncilcanada.ca/docs/rpts/2010/HSU/DecisionsHSU_Sept2010.pdf webcite]
• [20]Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ: Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med 2005, 20(3):278-282.
• [21]Janz NK, Becker MH: The Health Belief Model: A decade later. Health Educ Q 1984, 11(1):1-47.
• [22]Chan EC, Vernon SW: Implementing an intervention to promote colon cancer screening through e-mail over the internet: lessons learned from a pilot study. Med Care 2008, 46(Suppl 1):S117-S122.
• [23]Miller DP, Kimberly JR, Case LD, Wofford JL: Using a computer to teach patients about fecal occult blood screening. J Gen Intern Med 2005, 20(11):984-988.
• [24]Ahlquist DA: Occult blood screening. Obstacles to effectiveness. Cancer 1992, 70:1259-1265.
• [25]Sharma VK, Vasudeva R, Howden CW: Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey. Am J Gatrolenterol 2000, 95(6):1551-1556.
• [26]Wender RC: Barriers to screening for colorectal cancer. Gastrointest Endosc Clin N Am 2002, 12:145-170.
• [27]Statistics Canada: Canadian Internet Use Survey. [http://www.statscan.gc.ca. webcite]
• [28]Statistics Canada: CANSIM table 358–0130. [http://www.statscan.gc.ca. webcite]
• [29]Statistics Canada: CANSIM table 358–0129. [http://www.statscan.gc.ca. webcite]
• [30]Statistics Canada[http://www.gov.mb.ca/health/phc/pin/index.html webcite]
• [31]Sisler J, McCormack-Speak P: Bridging the gap between primary care and the cancer system. Canadian Family Physician 2009, 55(3):273-278.
• [32]Christie J, O’Halloran P, Stevenson M: Planning a cluster randomized controlled trial: methodological issues. Nurs Res 2009, 58(2):128-134.
• [33]Hintze J: NCSS and PASS. Kaysville, Utah; 2001. [Number Cruncher Statistical Systems] [http://www.ncss.com webcite]
• [34]Campbell MK, Thomsom S, Ramsay CR, MacLennan GS, Grimshaw JM: Sample size calculator for cluster randomized trials. Comput Biol Med 2004, 34:113-125.